CSIMarket



Becton Dickinson And Company  (BDX)
Other Ticker:  
 
 

BDX's Capital Expenditures Growth by Quarter and Year

Becton Dickinson And's Capital Expenditures results by quarter and year




BDX Capital Expenditures (in millions $) FY 2022 FY 2021 FY 2020 FY 2019
IV Quarter September - 465.00 213.00 358.00
III Quarter June - 267.00 202.00 237.00
II Quarter March 227.00 253.00 222.00 195.00
I Quarter December 188.00 246.00 173.00 167.00
FY   415.00 1,231.00 810.00 957.00



BDX Capital Expenditures second quarter 2022 Y/Y Growth Comment
Becton Dickinson And Company reported fall in Capital Expenditures in the second quarter 2022 by -10.28% to $ 227.00 millions, from the same quarter in 2021.
The decline in the second quarter 2022 Becton Dickinson And Company's Capital Expenditures compares unfavorably to the Company's average Capital Expenditures growth of 6.06%.

Looking into second quarter 2022 results within Medical Equipment & Supplies industry 85 other companies have achieved higher Capital Expenditures growth. While Becton Dickinson And Company' s Capital Expenditures decrease of -10.28% ranks overall at the positon no. 2144 in the second quarter 2022.




BDX Capital Expenditures ( Y/Y Growth %) 2022
2021 2020 2019
IV Quarter September - 118.31 % -40.5 % 16.61 %
III Quarter June - 32.18 % -14.77 % 20.3 %
II Quarter March -10.28 % 13.96 % 13.85 % -8.45 %
I Quarter December -23.58 % 42.2 % 3.59 % -6.18 %
FY   - 51.98 % -15.36 % 6.93 %

Financial Statements
Becton Dickinson And's second quarter 2022 Capital Expenditures $ 227.00 millions BDX's Income Statement
Becton Dickinson And's second quarter 2021 Capital Expenditures $ 253.00 millions Quarterly BDX's Income Statement
New: More BDX's historic Capital Expenditures Growth >>


BDX Capital Expenditures (Quarter on Quarter Growth %)

2022
2021 2020 2019
IV Quarter September - 74.16 % 5.45 % 51.05 %
III Quarter June - 5.53 % -9.01 % 21.54 %
II Quarter March 20.74 % 2.85 % 28.32 % 16.77 %
I Quarter December -59.57 % 15.49 % -51.68 % -45.6 %
FY (Year on Year)   - 51.98 % -15.36 % 6.93 %




Capital Expenditures second quarter 2022 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #86
Healthcare Sector #357
Overall #2144

Capital Expenditures Y/Y Growth Statistics
High Average Low
118.31 % 6.06 % -69.2 %
(Sep 30 2021)   (June 30. 2012)
Capital Expenditures second quarter 2022 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #86
Healthcare Sector #357
Overall #2144
Capital Expenditures Y/Y Growth Statistics
High Average Low
118.31 % 6.06 % -69.2 %
(Sep 30 2021)   (June 30. 2012)

Capital Expenditures by Quarter for the Fiscal Years 2019, 2020, 2021, 2022

Becton Dickinson And's Q/Q Capital Expenditures Growth


Capital Expenditures Q/Q Growth Statistics
High Average Low
292.11 % 19.2 % -85.14 %
(Sep 30 2015)  


BDX's II. Quarter Q/Q Capital Expenditures Comment
Becton Dickinson And Company achieved in the II. Quarter 2022 above company average sequential Capital Expenditures jump of 20.74%, to $ 227.00 millions, from $188.00 millions in the first quarter.
Medical Equipment & Supplies company is impressively improving, not only recording better then regular increase, but also accelerating speed, Finn Lambert, Healthcare sector observer located in Paris said.

Within Medical Equipment & Supplies industry 14 other companies have achieved higher Capital Expenditures quarter on quarter growth. While Becton Dickinson And's Capital Expenditures growth quarter on quarter, overall rank is 305.


Capital Expenditures Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #15
Healthcare Sector #53
Overall #305
Capital Expenditures Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #15
Healthcare Sector #53
Overall #305
Capital Expenditures Q/Q Growth Statistics
High Average Low
292.11 % 19.2 % -85.14 %
(Sep 30 2015)  


BDX's II. Quarter Q/Q Capital Expenditures Comment
Becton Dickinson And Company achieved in the II. Quarter 2022 above company average sequential Capital Expenditures jump of 20.74%, to $ 227.00 millions, from $188.00 millions in the first quarter.
Medical Equipment & Supplies company is undergoing a remarkable growth, not only recording higher then normal gain, and also increasing rate.

Within Medical Equipment & Supplies industry 14 other companies have achieved higher Capital Expenditures quarter on quarter growth. While Becton Dickinson And's Capital Expenditures growth quarter on quarter, overall rank is 305.


Becton Dickinson And's 12 Months Capital Expenditures Growth Year on Year


Capital Expenditures TTM Growth

12 Months Ending
(Mar 31 2022)
12 Months Ending
(Dec 31 2021)
12 Months Ending
(Sep 30 2021)
12 Months Ending
(Jun 30 2021)
12 Months Ending
(Mar 31 2021)
Cumulative Capital Expenditures 12 Months Ending $ 1,147.00 $ 1,173.00 $ 1,231.00 $ 979.00 $ 914.00
Y / Y Capital Expenditures Growth (TTM) 25.49 % 32.84 % 51.98 % 2.51 % -7.68 %
Year on Year Capital Expenditures Growth Overall Ranking # 1338 # 85 # 705 # 1216 # 1010
Seqeuential Capital Expenditures Change (TTM) -2.22 % -4.71 % 25.74 % 7.11 % 3.51 %
Seq. Capital Expenditures Growth (TTM) Overall Ranking # 2084 # 178 # 657 # 1368 # 789




Cumulative Capital Expenditures growth Comment
Assuming the Becton Dickinson And's fiscal year would have ended in Mar 31 2022, Becton Dickinson And would have reprted above average annual Capital Expenditures rise of 25.49% year on year, of $ 1,147 millions.
This marks a slow-down of the companys growth trends and from the 32.84% improvement in Dec 31 2021.

In the Healthcare sector 238 other companies have achieved higher trailing twelve month Capital Expenditures growth. While Capital Expenditures growth total ranking has deteriorated compare to previous quarter from 85 to 1338.

Capital Expenditures TTM Q/Q Growth Statistics
High Average Low
25.74 %
0.57 %
-41.19 %
 

Capital Expenditures TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 84
Healthcare Sector # 239
Overall # 1338

Capital Expenditures TTM Y/Y Growth Statistics
High Average Low
51.98 %
1.92 %
-59.07 %
 


Capital Expenditures TTM Q/Q Growth Company Ranking
Within: No.
Industry # 84
Sector # 341
S&P 500 # 2084
Cumulative Capital Expenditures growth Comment
Assuming the Becton Dickinson And's fiscal year would have ended in Mar 31 2022, Becton Dickinson And would have reprted above average annual Capital Expenditures rise of 25.49% year on year, of $ 1,147 millions.
This marks a slow-down of the companys growth trends and from the 32.84% improvement in Dec 31 2021.

In the Healthcare sector 238 other companies have achieved higher trailing twelve month Capital Expenditures growth. While Capital Expenditures growth total ranking has deteriorated compare to previous quarter from 85 to 1338.

Capital Expenditures TTM Q/Q Growth Statistics
High Average Low
25.74 %
0.57 %
-41.19 %
 


Capital Expenditures TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 84
Healthcare Sector # 239
Overall # 1338

Capital Expenditures TTM Y/Y Growth Statistics
High Average Low
51.98 %
1.92 %
-59.07 %
 


Capital Expenditures TTM Q/Q Growth Company Ranking
Within: No.
Industry # 84
Sector # 341
S&P 500 # 2084




Other Capital Expenditures Growth
Medical Equipment & Supplies Industry Capital Expenditures Growth Trends and Statistics
Healthcare Sector Capital Expenditures Growth Statistics
Capital Expenditures Growth Trends for overall market
BDX's Capital Expenditures Growth Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Capital Expenditures Growth
Lowest Ranking Capital Expenditures Growth
Capital Expenditures Growth for BDX's Competitors
Capital Expenditures Growth for Becton Dickinson And's Suppliers
Capital Expenditures Growth for BDX's Customers

You may also want to know
BDX's Annual Growth Rates BDX's Profitability Ratios BDX's Asset Turnover Ratio BDX's Dividend Growth
BDX's Roe BDX's Valuation Ratios BDX's Financial Strength Ratios BDX's Dividend Payout Ratio
BDX's Roa BDX's Inventory Turnover Ratio BDX's Growth Rates BDX's Dividend Comparisons



Companies with similar Capital Expenditures improvement for the quarter ending Mar 31 2022 within Healthcare SectorY/Y Change %Capital Expenditures for the quarter ending Mar 31 2022
Novan Inc.-0.64%$ -0.642 millions
Brookdale Senior Living Inc -1.00%$ -1.003 millions
Steris Plc-2.26%$ -2.264 millions
Alkermes Plc -2.44%$ -2.442 millions
Novabay Pharmaceuticals Inc -4.00%$ -4.000 millions
Shattuck Labs Inc -5.69%$ -5.686 millions
Morphic Holding inc -5.88%$ -5.882 millions
Fulcrum Therapeutics Inc -6.11%$ -6.107 millions
Vbi Vaccines Inc-7.37%$ -7.374 millions
Community Health Systems Inc -7.62%$ -7.619 millions
Sqz Biotechnologies Company-7.69%$ -7.692 millions
Tarsus Pharmaceuticals Inc -8.00%$ -8.000 millions
Inspire Medical Systems inc -8.02%$ -8.024 millions
Becton Dickinson And Company-10.28%$ -10.277 millions
Vertex Pharmaceuticals Inc-10.33%$ -10.329 millions
Xtant Medical Holdings Inc -10.70%$ -10.701 millions
Myriad Genetics Inc -11.27%$ -11.268 millions
Exact Sciences Corporation-11.33%$ -11.332 millions
Inogen Inc -11.41%$ -11.414 millions
Alphatec Holdings Inc -11.81%$ -11.808 millions
Avanos Medical Inc -12.28%$ -12.281 millions
Merck and Co Inc -13.23%$ -13.228 millions
Genocea Biosciences Inc -13.35%$ -13.345 millions
Abbvie Inc -13.83%$ -13.830 millions
Acadia Healthcare Company Inc -13.90%$ -13.897 millions
Procyon Corp-14.32%$ -14.319 millions
Ocugen Inc -14.56%$ -14.559 millions
Therapeutic Solutions International Inc.-14.97%$ -14.974 millions
Davita Inc -15.05%$ -15.047 millions
Biolife Solutions Inc-15.35%$ -15.349 millions


       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

SVFB's Profile

Stock Price

SVFB's Financials

Business Description

Fundamentals

Charts & Quotes

SVFB's News

Suppliers

SVFB's Competitors

Customers & Markets

Economic Indicators

SVFB's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2022 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071